Son Truong Nguyen

Rani Therapeutics (United States)

论文数

4

总引用数

8

H-Index

2

关于

暂无简介。

研究焦点

Pharmacology4 · 8 次引用
Medicine4 · 8 次引用
Bioavailability2 · 4 次引用
Internal medicine2 · 4 次引用
Pill2 · 4 次引用
Ustekinumab1 · 2 次引用
Stock (firearms)1 · 2 次引用
Biosimilar1 · 2 次引用

主要成就

2
H 指数
4
论文
8
总引用数
2
篇均引用
🏆 最高被引论文
SAT235 An Orally Administered Robotic Pill (RP) Reliably And Safely Delivers the Human Parathyroid Hormone Analog hPTH(1-34) (Teriparatide) With High Bioavailability in Healthy Human Volunteers: A Phase 1 Study
2 次引用 · 2023
📈 最高产年份: 2023 (3 论文)
🤝 主要合作者: 22
🏛 所属机构: Rani Therapeutics (United States)

代表论文

  1. 1
    SAT235 An Orally Administered Robotic Pill (RP) Reliably And Safely Delivers the Human Parathyroid Hormone Analog hPTH(1-34) (Teriparatide) With High Bioavailability in Healthy Human Volunteers: A Phase 1 Study
    2 次引用 · 2023
  2. 2
    AN ORALLY ADMINISTERED ROBOTIC PILL (RP) RELIABLY AND SAFELY DELIVERS AN USTEKINUMAB BIOSIMILAR WITH HIGH BIOAVAILABILITY RELATIVE TO SUBCUTANEOUS (SC) USTEKINUMAB IN HEALTHY HUMAN PARTICIPANTS
    2 次引用 · 2024
  3. 3
    FRI415 Patient Preference And Proof-of-concept For A Once-daily Follicle Stimulating Hormone (FSH) Biosimilar Delivered Via An Orally Ingestible Robotic Pill (RT-112)
    2 次引用 · 2023
  4. 4
    SAT236 Pharmacokinetics (PK) And Pharmacodynamics (PD) Of The Parathyroid Hormone Analog PTH (1-34) (Teriparatide) Delivered Via An Orally Administered Robotic Pill (RT-102)
    2 次引用 · 2023

主要合作者

AKArvinder K. Dhalla4 篇合著论文BSBaber Syed4 篇合著论文MAMir A. Hashim4 篇合著论文KHKyle Horlen4 篇合著论文MIMir Imran4 篇合著论文ATApril Toledo Vo4 篇合著论文AYAlyson Yamaguchi4 篇合著论文LCLeonard C. Fung3 篇合著论文NPNidhi Patel2 篇合著论文ADAnvesh Dasari2 篇合著论文JMJoshua Myers2 篇合著论文KKKristina Kaminskaya2 篇合著论文JVJacques Van Dam2 篇合著论文ABArchana Battiwala1 篇合著论文VNVy Nguyen1 篇合著论文RLRamya Lekha Medida1 篇合著论文VTVinh Thanh Tran1 篇合著论文NPNidhi Patel1 篇合著论文NPNidhi Patel1 篇合著论文HKHeather Kennedy1 篇合著论文
尚未生成